Found: 27
Select item for more details and to access through your institution.
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38364-y
- By:
- Publication type:
- Article
MiRNAs in renal cell carcinoma.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2055, doi. 10.1007/s12094-022-02866-z
- By:
- Publication type:
- Article
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 801, doi. 10.3390/ijms24010801
- By:
- Publication type:
- Article
Molecular characterization of triple negative breast cancer formaldehyde‐fixed paraffin‐embedded samples by data‐independent acquisition proteomics.
- Published in:
- Proteomics, 2022, v. 22, n. 3, p. 1, doi. 10.1002/pmic.202100110
- By:
- Publication type:
- Article
Functional proteomics of colon cancer Consensus Molecular Subtypes.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 10, p. 1670, doi. 10.1038/s41416-024-02650-6
- By:
- Publication type:
- Article
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.
- Published in:
- Ecancermedicalscience, 2019, v. 13, n. 890-910, p. 1, doi. 10.3332/ecancer.2019.891
- By:
- Publication type:
- Article
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.
- Published in:
- Ecancermedicalscience, 2016, v. 10, n. 630-650, p. 1, doi. 10.3332/ecancer.2016.632
- By:
- Publication type:
- Article
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
- Published in:
- Metabolomics, 2023, v. 19, n. 7, p. 1, doi. 10.1007/s11306-023-02024-8
- By:
- Publication type:
- Article
The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109611
- By:
- Publication type:
- Article
PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033752
- By:
- Publication type:
- Article
Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005911
- By:
- Publication type:
- Article
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 16, p. 2581, doi. 10.1002/cncr.34797
- By:
- Publication type:
- Article
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 5, p. 1031
- By:
- Publication type:
- Article
Bayesian networks established functional differences between breast cancer subtypes.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234752
- By:
- Publication type:
- Article
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86966-w
- By:
- Publication type:
- Article
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-023-02931-7
- By:
- Publication type:
- Article
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178296
- By:
- Publication type:
- Article
An 8-gene qRT-PCR-based gene expression scorethat has prognostic value in early breast cancer.
- Published in:
- BMC Cancer, 2010, v. 10, p. 336, doi. 10.1186/1471-2407-10-336
- By:
- Publication type:
- Article
Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes.
- Published in:
- Human Mutation, 2007, v. 28, n. 12, p. 1245, doi. 10.1002/humu.9512
- By:
- Publication type:
- Article
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4407, doi. 10.3390/cancers15174407
- By:
- Publication type:
- Article
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1104, doi. 10.3390/cancers15041104
- By:
- Publication type:
- Article
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2414, doi. 10.3390/cancers14102414
- By:
- Publication type:
- Article
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229075
- By:
- Publication type:
- Article
Proteomics Characterization of Clear Cell Renal Cell Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 384, doi. 10.3390/jcm12010384
- By:
- Publication type:
- Article
Shotgun proteomics of archival triple-negative breast cancer samples.
- Published in:
- Proteomics - Clinical Applications, 2013, v. 7, n. 3/4, p. 283, doi. 10.1002/prca.201200048
- By:
- Publication type:
- Article
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.
- Published in:
- 2019
- By:
- Publication type:
- journal article